Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03856086 · ClinicalTrials.gov registry record · NA

Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients

A NA study of Cancer Caregivers, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT03856086: Completed NA study of Cancer Caregivers, sponsored by Memorial Sloan Kettering Cancer Center.

NCT03856086 is a NA study of Cancer Caregivers that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03856086, a NA study of Cancer Caregivers, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study will help the researchers find out whether the S+C approach is better, the same as, or worse than EUC.

Primary Outcome

comparing the 3-month change scores on the NCCN problem list from baseline

Conditions Studied

Interventions

  • BEHAVIORAL Baseline questionnaire
  • BEHAVIORAL NCCN Problem List
  • BEHAVIORAL FACT-GP
  • BEHAVIORAL HADS
  • BEHAVIORAL CSS-CG

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2019-02-25
Est. Completion 2025-11-12
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT03856086 record still lists

NCT03856086 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Cancer Caregivers appearing as the primary indexed condition, and to 5 interventions - of which Baseline questionnaire is the first listed.

NCT03856086 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03856086 about?

NCT03856086 is a clinical study titled "Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients". This study will help the researchers find out whether the S+C approach is better, the same as, or worse than EUC.

What is the current status of trial NCT03856086?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2019-02-25. Estimated completion is 2025-11-12.

What conditions does trial NCT03856086 study?

This clinical trial studies the following conditions: Cancer Caregivers.

What interventions are being tested in trial NCT03856086?

The interventions under investigation include: Baseline questionnaire (BEHAVIORAL), NCCN Problem List (BEHAVIORAL), FACT-GP (BEHAVIORAL), HADS (BEHAVIORAL), CSS-CG (BEHAVIORAL).

Who is sponsoring clinical trial NCT03856086?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03856086 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03856086's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03856086, the US trial registry maintained by the National Library of Medicine. NCT03856086 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.